Treatment of Stage I Bladder carcinoma includes all except
Urothelial tumors that have not invaded the detrusor muscle are termed non-muscle invasive bladder cancers (NMIBCs). Approximately 70% of patients who present with bladder cancer will be diagnosed with NMBIC, which includes T stages Tis (carcinoma in situ), Ta, and T1 Any tumor identified in the bladder should be fully resected by TURBT. (trans urethral resection of bladder tumor) Single-dose intravesical chemotherapy administered within 6 hours of resection reduces recurrence of low-risk tumors, with significant impact in the setting of initial presentation of solitary low-grade papillary tumors. Intravesicular delivery of Bacillus Calmette-Guerin (BCG) is also used to treat and prevent the recurrence of superficial tumors. BCG is given 2 to 4 weeks after tumor resection,allowing time for re-epithelialization.
Local excision
Intravesical Chemotherapy
Radiotherapy
BCG
Urology